Acrylyl-PAF, a synthetic platelet-activating factor analogue

Area of Science:

• Biochemistry
• Pharmacology
• Lipid Signaling

Background:

• Platelet-activating factor (PAF) is a potent lipid mediator involved in inflammation and hemostasis.
• Human serum acetylhydrolase (HSA) is a key enzyme responsible for PAF metabolism.
• Novel PAF analogues are crucial for understanding PAF receptor interactions and developing therapeutic strategies.

Purpose of the Study:

• To synthesize and characterize acrylyl-PAF, a novel PAF analogue.
• To investigate the inhibitory effects of acrylyl-PAF on human serum acetylhydrolase.
• To evaluate the agonist properties and metabolic fate of acrylyl-PAF in biological systems.

Main Methods:

• Synthesis of acrylyl-PAF from lyso-PAF and acrylyl chloride.
• Enzyme kinetics studies using acetylhydrolase with PAF and acrylyl-PAF.
• Platelet aggregation assays and perfused rat liver studies.
• Metabolic stability assessment using radiolabeled compounds and tissue analysis.

Main Results:

• Acrylyl-PAF competitively inhibited human serum acetylhydrolase with a Ki of 2.6 µM.
• Acrylyl-PAF exhibited approximately 60% lower metabolism by acetylhydrolase compared to PAF.
• Acrylyl-PAF aggregated platelets and stimulated hepatic glycogenolysis, albeit with lower potency than PAF.
• In perfused livers, acrylyl-PAF showed reduced conversion to lyso-PAF and increased stability compared to PAF.
• Repeated acrylyl-PAF infusions led to desensitization of the hepatic glycogenolytic response.

Conclusions:

• Acrylyl-PAF is a poorly hydrolyzed, competitive inhibitor of acetylhydrolase.
• Acrylyl-PAF retains significant agonist activity for platelet aggregation and hepatic glycogenolysis.
• Acrylyl-PAF's distinct metabolic profile and desensitization properties offer insights into PAF signaling pathways.